Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study

Bosnian Journal of Basic Medical Sciences - Bosnia and Herzegovina
doi 10.17305/bjbms.2017.2279

Related search